ENTITY
Bayer

Bayer (BAYN GR)

72
Analysis
Health Care • Germany
Bayer AG produces and markets healthcare and agricultural products. The Company manufactures products that include aspirin, antibiotics, anti-infectives, cardiovascular, oncology, central nervous system drugs, over-the-counter medications, diagnostics, and animal health products, as well as crop protection products, plastics, and polyurethanes.
more
bullish•PLx Pharma
•14 Oct 2021 21:48

PLXP: Headlines to Buy

News headlines of medical opinion on taking aspirin daily should be construed as a positive for PLXP and its drug VAZALORE. Negative opinion on...

Logo
374 Views
Share
bullish•PharmaSGP
•12 Jun 2020 19:46

PharmaSGP IPO Initiation: Potent Medicine

PharmaSGP (1780644D GR) is a pure-play consumer health company with a broad portfolio of leading chemical-free non-prescription pharmaceuticals...

Logo
537 Views
Share
•24 May 2020 16:54

Burning Rock Biotech IPO Initiation: Burning Ambitions

Burning Rock Biotech (BNR US) is a precision oncology and early cancer detection company. It is China’s number one NGS-based cancer therapy...

Logo
455 Views
Share
•14 Aug 2019 16:45

CStone Pharma's (基石药业) Lock-Up Expiry - Lack of Material Newsflow for Core Drug Candidates

Lock-up restriction for Cstone Pharma's pre-IPO investors and cornerstone investors will expire on August 26th. As we expect roughly USD 1 billion...

Logo
746 Views
Share
bullish•DowDuPont Inc
•05 Jun 2019 01:09

SpinTalk: Focus On Corteva Agriscience (CTVA US) - An Attractive Long Term Investment Proposition

The Creation Of A Unique Pure-Play AgribusinessSome 20 months after Dow Chemicals and DuPont completed their ‘Merger of Equals’ in August 2017 to...

Logo
767 Views
Share
x